These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15296275)

  • 21. Serogroup B meningococcal vaccines.
    Zimmer SM; Stephens DS
    Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteraemia in children in Iceland 1994-2005].
    Arnason S; Thors VS; Gudnason T; Kristinsson KG; Haraldsson A
    Laeknabladid; 2008 Jul; 94(7-8):523-9. PubMed ID: 18591727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningococcal disease.
    Daley AJ
    Aust Fam Physician; 2003 Aug; 32(8):597-601, 603-5. PubMed ID: 12973866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and outcome of bacterial meningitis in Canadian children: 1998-1999.
    Husain E; Chawla R; Dobson S; Dele Davies H;
    Clin Invest Med; 2006 Jun; 29(3):131-5. PubMed ID: 17058430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial profile and clinical outcome of childhood meningitis in rural Yemen: a 2-year hospital-based study.
    Al Khorasani A; Banajeh S
    J Infect; 2006 Oct; 53(4):228-34. PubMed ID: 16434101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden and etiology of community-acquired bacterial meningitis in a hospital in Eastern Saudi Arabia: 1993-2005.
    Al-Tawfiq JA; Abukhamsin A
    Med Sci Monit; 2009 Feb; 15(2):PI10-14. PubMed ID: 19179978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New therapies and vaccines for bacterial meningitis.
    Foster C; Nadel S
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1051-60. PubMed ID: 12150701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003.
    Soriano-Gabarró M; Toé L; Tiendrebeogo SR; Nelson CB; Dabal M; Djingarey MH; Plikaytis B; Rosenstein N;
    Vaccine; 2007 Sep; 25 Suppl 1():A92-6. PubMed ID: 17517451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of meningococcal serogroup C disease by NeisVac-C.
    Borrow R; Findlow J
    Expert Rev Vaccines; 2009 Mar; 8(3):265-79. PubMed ID: 19249967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
    Pace D
    Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bacteriology of community acquired meningitis in Sfax, Tunisia (1993-2001)].
    Maalej SM; Kassis M; Rhimi FM; Damak J; Hammami A
    Med Mal Infect; 2006 Feb; 36(2):105-10. PubMed ID: 16459040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding prevention of invasive meningococcal disease.
    Pelton SI; Gilmet GP
    Expert Rev Vaccines; 2009 Jun; 8(6):717-27. PubMed ID: 19485753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case-fatality ratio of bacterial meningitis in the African meningitis belt: we can do better.
    Boisier P; Maïnassara HB; Sidikou F; Djibo S; Kairo KK; Chanteau S
    Vaccine; 2007 Sep; 25 Suppl 1():A24-9. PubMed ID: 17521784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serious community-acquired paediatric infections in rural Asia (Bohol Island, Philippines): bacterial meningitis in children less than 5 years of age.
    Abucejo-Ladesma E; Simoes EA; Lupisan SP; Sombrero LT; Quiambao BP; Gozum LS; Herva E; Ruutu P;
    Scand J Infect Dis; 2007; 39(11-12):983-9. PubMed ID: 17852943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
    Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 May; 33(ACS-3):1-23. PubMed ID: 17520774
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135.
    Djibo S; Njanpop Lafourcade BM; Boisier P; Moussa A; Kobo G; Sidikou F; Hien A; Bieboure G; Aguilera JF; Parent du Chatelet I; Gessner BD; Chanteau S
    Trans R Soc Trop Med Hyg; 2006 Jun; 100(6):573-8. PubMed ID: 16406096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical aspects and outcome of meningococcal disease due to Neisseria meningitidis of serogroup W135 in 5 children].
    Faye A; Mariani-Kurkjian P; Taha MK; Louzeau C; Bingen E; Bourrillon A
    Arch Pediatr; 2005 Mar; 12(3):291-4. PubMed ID: 15734127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quadrivalent meningococcal conjugate vaccines.
    Pace D; Pollard AJ; Messonier NE
    Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.